OLIO Financial Planning Takes Position in Intuitive Surgical, Inc. (NASDAQ:ISRG)

OLIO Financial Planning acquired a new stake in shares of Intuitive Surgical, Inc. (NASDAQ:ISRG) in the 1st quarter, according to its most recent Form 13F filing with the Securities and Exchange Commission. The fund acquired 1,175 shares of the medical equipment provider’s stock, valued at approximately $582,000.

Other institutional investors also recently made changes to their positions in the company. Atala Financial Inc purchased a new stake in shares of Intuitive Surgical during the 4th quarter valued at $25,000. Parvin Asset Management LLC purchased a new stake in Intuitive Surgical during the 4th quarter worth $26,000. Global Financial Private Client LLC boosted its position in Intuitive Surgical by 253.3% during the 1st quarter. Global Financial Private Client LLC now owns 53 shares of the medical equipment provider’s stock worth $26,000 after purchasing an additional 38 shares during the period. BankPlus Trust Department purchased a new stake in Intuitive Surgical during the 4th quarter worth $28,000. Finally, Hurley Capital LLC purchased a new stake in Intuitive Surgical during the 4th quarter worth $28,000. 83.64% of the stock is owned by hedge funds and other institutional investors.

Wall Street Analysts Forecast Growth

A number of analysts recently weighed in on ISRG shares. Citigroup reaffirmed a “buy” rating and set a $650.00 price target (up from $590.00) on shares of Intuitive Surgical in a research report on Thursday, May 22nd. Truist Financial decreased their price target on shares of Intuitive Surgical from $605.00 to $590.00 and set a “buy” rating for the company in a research report on Wednesday, April 23rd. Evercore ISI decreased their price target on shares of Intuitive Surgical from $510.00 to $470.00 and set an “in-line” rating for the company in a research report on Wednesday, April 23rd. Erste Group Bank raised shares of Intuitive Surgical from a “hold” rating to a “buy” rating in a research report on Thursday. Finally, Barclays decreased their price target on shares of Intuitive Surgical from $684.00 to $635.00 and set an “overweight” rating for the company in a research report on Thursday, April 24th. Four equities research analysts have rated the stock with a hold rating and fifteen have assigned a buy rating to the stock. According to data from MarketBeat.com, the stock presently has a consensus rating of “Moderate Buy” and a consensus price target of $596.05.

Insider Buying and Selling

In related news, Director Jami K. Nachtsheim sold 2,400 shares of the stock in a transaction dated Thursday, May 1st. The shares were sold at an average price of $520.00, for a total transaction of $1,248,000.00. Following the sale, the director now owns 6,371 shares in the company, valued at $3,312,920. This represents a 27.36% decrease in their ownership of the stock. The transaction was disclosed in a legal filing with the Securities & Exchange Commission, which is available through this hyperlink. Also, EVP Robert Desantis sold 11,545 shares of the stock in a transaction dated Thursday, March 13th. The stock was sold at an average price of $499.22, for a total transaction of $5,763,494.90. Following the sale, the executive vice president now owns 5,224 shares in the company, valued at approximately $2,607,925.28. This trade represents a 68.85% decrease in their position. The disclosure for this sale can be found here. Insiders have sold a total of 25,443 shares of company stock worth $12,692,195 over the last quarter. 0.70% of the stock is owned by company insiders.

Intuitive Surgical Stock Performance

Shares of Intuitive Surgical stock opened at $557.08 on Friday. The firm has a market cap of $199.67 billion, a PE ratio of 86.91, a price-to-earnings-growth ratio of 5.85 and a beta of 1.67. The firm’s 50-day simple moving average is $521.99 and its 200-day simple moving average is $539.26. Intuitive Surgical, Inc. has a 1 year low of $413.52 and a 1 year high of $616.00.

Intuitive Surgical (NASDAQ:ISRG) last issued its earnings results on Tuesday, April 22nd. The medical equipment provider reported $1.81 earnings per share (EPS) for the quarter, beating analysts’ consensus estimates of $1.71 by $0.10. The business had revenue of $2.25 billion for the quarter, compared to analyst estimates of $2.19 billion. Intuitive Surgical had a net margin of 27.81% and a return on equity of 14.55%. During the same quarter in the prior year, the business posted $1.50 EPS. On average, equities analysts predict that Intuitive Surgical, Inc. will post 6.43 earnings per share for the current year.

Intuitive Surgical Profile

Intuitive Surgical, Inc develops, manufactures, and markets products that enable physicians and healthcare providers to enhance the quality of and access to minimally invasive care in the United States and internationally. The company offers the da Vinci Surgical System that enables complex surgery using a minimally invasive approach; and Ion endoluminal system, which extends its commercial offerings beyond surgery into diagnostic procedures enabling minimally invasive biopsies in the lung.